Skinmed : Impact Factor & More
pISSN: 1540-9740
Share this on:
Key Metrics
SJR 
Q3Medicine (all)
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Skinmed Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Le Jacq Communications, Inc. |
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Skinmed
BIMZELX® (Bimekizumab-bkzx) Injection, for Subcutaneous Use.
- 1 Jan 2024
- Skinmed
XdemvyTM (Lotilaner Ophthalmic Solution) 0.25% Topical Solution for the Treatment of Demodex Blepharitis.
- 1 Jan 2024
- Skinmed
Dermatology in Correctional Health: A Pilot Survey Study.
- 1 Jan 2024
- Skinmed
Diagnostic Dilemma of an Adult-Onset Vascular Tumor.
- 1 Jan 2024
- Skinmed
Pseudoxanthoma Elasticum-Like Changes:Associations- and Underlying Mechanisms.
- 1 Jan 2024
- Skinmed
Libtayo® (Cemiplimab-rwlc) Injection for Intravenous Use.
- 1 Jan 2024
- Skinmed
BIMZELX® (Bimekizumab-bkzx) Injection, for Subcutaneous Use.
- 1 Jan 2024
- Skinmed
XdemvyTM (Lotilaner Ophthalmic Solution) 0.25% Topical Solution for the Treatment of Demodex Blepharitis.
- 1 Jan 2024
- Skinmed
Dermatology in Correctional Health: A Pilot Survey Study.
- 1 Jan 2024
- Skinmed
Diagnostic Dilemma of an Adult-Onset Vascular Tumor.
- 1 Jan 2024
- Skinmed
Pseudoxanthoma Elasticum-Like Changes:Associations- and Underlying Mechanisms.
- 1 Jan 2024
- Skinmed
Libtayo® (Cemiplimab-rwlc) Injection for Intravenous Use.
- 1 Jan 2024
- Skinmed
FAQs on Skinmed
How many articles did Skinmed publish last year? 
What is the SJR for Skinmed?
Who is the publisher of Skinmed?
